BE at Steady state [Design Issues]

posted by Ahmed meeran – 2006-09-12 08:10 (7211 d 03:56 ago) – Posting: # 249
Views: 13,428

Dear Dr. Helmut

All the regulatory guidlines talks about conducting Bioequivalence study in single dose and at steady state conditions. For which type of drugs conducting a Bioequivalence study at steady state conditions is necessary.

For performing Bioequivalence study at steady state whether the sample size calculation is same as that of single dose study.

If Bioequivalence study is performed at steady state whether it will meet the acceptance criteria with small no of subjects than a single dose study.

Please guide me in these issues

Ahmed

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
225 visitors (0 registered, 225 guests [including 14 identified bots]).
Forum time: 12:06 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5